JP2021512148A5 - - Google Patents
Info
- Publication number
- JP2021512148A5 JP2021512148A5 JP2020561572A JP2020561572A JP2021512148A5 JP 2021512148 A5 JP2021512148 A5 JP 2021512148A5 JP 2020561572 A JP2020561572 A JP 2020561572A JP 2020561572 A JP2020561572 A JP 2020561572A JP 2021512148 A5 JP2021512148 A5 JP 2021512148A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- e4orf1
- npc
- sci
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862620269P | 2018-01-22 | 2018-01-22 | |
| US62/620,269 | 2018-01-22 | ||
| PCT/US2019/014497 WO2019144102A1 (en) | 2018-01-22 | 2019-01-22 | Compositions and methods for treatment of spinal cord injury |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512148A JP2021512148A (ja) | 2021-05-13 |
| JP2021512148A5 true JP2021512148A5 (enExample) | 2022-02-24 |
| JP7391308B2 JP7391308B2 (ja) | 2023-12-05 |
Family
ID=67301897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561572A Active JP7391308B2 (ja) | 2018-01-22 | 2019-01-22 | 脊髄損傷の治療のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210030810A1 (enExample) |
| EP (1) | EP3743085A4 (enExample) |
| JP (1) | JP7391308B2 (enExample) |
| CN (1) | CN111886016A (enExample) |
| AU (1) | AU2019209439A1 (enExample) |
| CA (1) | CA3089324A1 (enExample) |
| WO (1) | WO2019144102A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2753441C2 (ru) | 2016-09-13 | 2021-08-16 | Ангиокрин Биосайенс, Инк. | Гематоэнцефалический барьер, содержащий сконструированные эндотелиальные клетки |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465732B2 (en) * | 2007-01-19 | 2013-06-18 | Cornell Research Foundation, Inc. | Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof |
| KR101675123B1 (ko) * | 2014-06-27 | 2016-11-14 | 연세대학교 산학협력단 | Psa-ncam-양성 신경전구세포를 유효성분으로 포함하는 허혈성 질환 또는 신경염증 질환 치료용 조성물 |
| EP3584312A1 (en) * | 2014-06-27 | 2019-12-25 | Angiocrine Bioscience, Inc. | Neural cells expressing adenovirus e4orf1, and methods of making and using the same |
| EP3315133B1 (en) * | 2015-06-26 | 2020-07-22 | S-Biomedics | Composition for treating ischemic diseases or neurogenic inflammatory disorders, containing secretome of neural progenitor cells as active ingredient |
| EP3325613A4 (en) * | 2015-07-20 | 2018-12-19 | Angiocrine Bioscience, Inc. | Engineered endothelial cells expressing an ets transcription factor |
-
2019
- 2019-01-22 EP EP19741215.8A patent/EP3743085A4/en not_active Withdrawn
- 2019-01-22 CA CA3089324A patent/CA3089324A1/en active Pending
- 2019-01-22 JP JP2020561572A patent/JP7391308B2/ja active Active
- 2019-01-22 AU AU2019209439A patent/AU2019209439A1/en not_active Abandoned
- 2019-01-22 US US16/963,897 patent/US20210030810A1/en not_active Abandoned
- 2019-01-22 WO PCT/US2019/014497 patent/WO2019144102A1/en not_active Ceased
- 2019-01-22 CN CN201980020725.8A patent/CN111886016A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20200143407A (ko) | Cgrp를 억제하는데 사용하기 위한 신경독소 | |
| JP2010523264A5 (enExample) | ||
| US12109181B2 (en) | Lidocaine patch and methods of use thereof | |
| JP5819733B2 (ja) | 障害および疾患に対する全身治療のためのＴＧＦ−βスーパーファミリーメンバー含有タンパク質の末梢投与 | |
| ES2946262T3 (es) | Lámina de liberación sostenida de fármaco para el tratamiento de la lesión nerviosa | |
| US10202598B2 (en) | Methods and systems for generation, use, and delivery of activated stem cells | |
| JP2002532432A5 (enExample) | ||
| CN107072716A (zh) | 用于产生和使用活化的干细胞的方法和系统 | |
| Stenslik et al. | Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease | |
| JP2020511548A (ja) | 治療用のボツリヌス神経毒素 | |
| RS64809B1 (sr) | Postupak za generisanje, upotrebu i isporuku aktiviranih matičnih ćelija | |
| DE60021360T2 (de) | Vegf angiogenische wachstumsfaktoren zur behandlung von peripherer neuropathie | |
| CN103705910A (zh) | 一种齐考诺肽注射型皮下植入剂及其制备方法 | |
| JP2016516071A (ja) | 瘢痕形成を軽減するためのｓｄｆ−１の使用 | |
| US20240189382A1 (en) | Formula for inhibiting aging regeneration repair | |
| JP2019526584A5 (enExample) | ||
| CN1278184A (zh) | 预防或治疗局部缺血性疾病的药剂 | |
| Ryabov et al. | Collagen Implant and Mononuclear Cells of Umbilical Blood Allow the Restore of Movements of Hind Limbs after Removing the Site of Spinal Cord. | |
| Gutmann | Heat-induced myasthenic crisis | |
| RU2122844C1 (ru) | Способ лечения герпетического кератита с изъязвлением | |
| US12616717B2 (en) | Regenerative CO2 treatment apparatus and method | |
| JP5819734B2 (ja) | ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法 | |
| JP6977979B2 (ja) | 神経損傷治療又は予防用医薬 | |
| JP4775940B2 (ja) | アロディニアの治療、改善、予防剤 | |
| RU2462280C1 (ru) | Способ цитофлавин-электрокумуляции при лечении сосудистых и дистрофических заболеваний сетчатки и зрительного нерва |